These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21355960)

  • 41. Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland.
    Czyz W; Balcerczak E; Rudowicz M; Niewiadomska H; Pasieka Z; Kuzdak K; Mirowski M
    Folia Histochem Cytobiol; 2003; 41(2):91-5. PubMed ID: 12722795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant expression of tumor-associated carbohydrate antigen Globo H in thyroid carcinoma.
    Cheng SP; Yang PS; Chien MN; Chen MJ; Lee JJ; Liu CL
    J Surg Oncol; 2016 Dec; 114(7):853-858. PubMed ID: 27753098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoembryonic antigen mRNA in blood: distinguishing follicular thyroid carcinoma from adenoma.
    Sato T; Nakano S; Yamashita J
    Thyroid; 2003 Sep; 13(9):891-2. PubMed ID: 14588107
    [No Abstract]   [Full Text] [Related]  

  • 45. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles.
    Pauws E; Veenboer GJ; Smit JW; de Vijlder JJ; Morreau H; Ris-Stalpers C
    FASEB J; 2004 Mar; 18(3):560-1. PubMed ID: 14715705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nm23 protein expression in thyroid neoplasms.
    Royds JA; Silcocks PB; Rees RC; Stephenson TJ
    Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comment on: synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland.
    Wasim NA; Hati GC; Guha D; Bhattacharya S
    Indian J Pathol Microbiol; 2011; 54(2):434-5. PubMed ID: 21623130
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.
    Gianoukakis AG; Giannelli SM; Salameh WA; McPhaul LW
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):9-20. PubMed ID: 21094678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
    Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W
    Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.
    Cameselle-Teijeiro J; Pardal F; Eloy C; Ruiz-Ponte C; Celestino R; Castro P; Soares P; Sobrinho-Simões M
    Hum Pathol; 2008 Oct; 39(10):1540-7. PubMed ID: 18602667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.
    Bhargav PR; Gayathri KB
    Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
    Perigli G; Cicchi P; Cianchi F; Artusi R; Olivari D; Caldini A; Cortesini C
    J Exp Clin Cancer Res; 1998 Mar; 17(1):113-6. PubMed ID: 9646245
    [No Abstract]   [Full Text] [Related]  

  • 59. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Approach to thyroid incidentaloma and follicular adenoma].
    Tajiri J
    Nihon Rinsho; 2007 Nov; 65(11):2099-105. PubMed ID: 18018577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.